Navigation Links
Oxford Performance Materials Acquired By Arkema
Date:2/9/2009

OPM Expands Position within High Performance Polymer Market Place

Enfield, CT (PRWEB) February 9, 2009 -- Arkema has announced the acquisition of Oxford Performance Materials, Inc. (OPM), maker of OXPEKK® products. OPM will operate as an Arkema subsidiary from its Enfield, CT headquarters with the established management team. The firm will continue its commercial focus on advanced medical and industrial applications for its proprietary materials. OXPEKK® products are currently used in commercial jetliners, long-term medical implants, and demanding energy applications, including down-hole tools and pumps.

OXPEKK® polyether ketone ketone is a high-temperature and chemically resistant, semi-crystalline thermoplastic with exceptional abrasion resistance and natural flame retardancy. "The addition of OXPEKK® products to Arkema's diverse portfolio complements a set of high-performance plastics than include high-purity Kynar® Rx PVDF, biocompatible Pebax® polyether block amides, medical-grade Plexiglas® PMMA, and food-contact-compliant Biostrength® polymer additives," said Homero Endara, commercial development manager for Arkema, Inc.

"Arkema has had a long-standing interest in ultra-high-performance polymers and we have looked at strategic opportunities in the past. It was our desire to find the right combination of management committed to exploiting the medical and high-tech market space and a product that offered outstanding technical differentiation," said Ryan Dirkx, V.P. of Research and Development for Arkema, Inc. "We are delighted to have concluded this transaction and look forward to supporting OPM with the capabilities of Arkema's global organization."

"OPM has spent nearly ten years perfecting the polyethyl ketone ketone (PEKK) molecule with the help of venture capital," said Scott DeFelice, President and CEO of OPM. "Now with Arkema, we can broaden our industrial strategy and pursue more market opportunities. OPM's single-minded focus on PEKK and Arkema's polymer competencies and capabilities will be a formidable combination in the high-performance polymer marketplace."

About OPM
Founded in March 2000, OPM has rapidly become an industry leader in the ultra-high performance thermoplastic polymers market. The firm's versatile OXPEKK® polymers are currently being used in medical, space and defense, semiconductor and industrial markets worldwide. OPM is ISO 9001:2000 and ISO 13485:2003 registered. For additional information, please visit www.oxfordpm.com.

About Arkema
A global chemical company and France's leading chemicals producer, Arkema consists of three strategically related businesses: Vinyl Products, Industrial Chemicals, and Performance Products. Arkema reported sales of 5.7 billion euros in 2007. Arkema has 15,200 employees across over 40 countries and six research centers located in France, the United States and Japan. With internationally recognized brands, Arkema holds leadership positions in its principal markets.
www.arkema.com
www.arkema-inc.com

OXPEKK® is a registered trademark belonging to Oxford Performance Materials, Inc.
Kynar® and Biostrength® are trademarks belonging to Arkema, Inc.
Pebax® is a trademark belonging to Arkema.
Plexiglas® is a trademark belonging to Altuglas International.

# # #

Read the full story at http://www.prweb.com/releases/2009/02/prweb1970894.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related medicine news :

1. Oxford Performance Materials Received ISO 13485 and ISO 9001 Certification
2. AIDS Activists from Across the Country Converge on Oxford, Mississippi, to Call on McCain and Obama to Commit to National AIDS Strategy
3. Curemark CEO Presents Autism Findings at Prestigious Neurobiology Conference at Oxford
4. Varian, Inc. Acquires Oxford Diffraction, Ltd.
5. ESMO, Oxford Journals and the Japanese Society of Medical Oncology announce collaboration
6. Journal of American College of Surgeons study finds warm-up helps surgeons improve performance
7. Abaxis Reports Financial Performance for the Third Quarter of Fiscal 2009
8. KPMG and Trintech Collaborate to Enable Bay Area Users Group of Trintech Customers to Optimize Their Investments in Technology and Deliver Improved Performance in Turbulent Economic Times
9. AMDL, Inc. Completes Revision of Performance & Equity Incentive Compensation Plan
10. Synthetech Earns National Recognition for Performance Improvement Program
11. Park Avenue Nursing and Rehabilitation Center Selects PatientPlacement.com Web-based Long-Term Care Software to Automate Admissions and Boost Census Performance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... June 27, 2016 , ... "FCPX editors can now ... of Final Cut Pro X," said Christina Austin - CEO of Pixel Film Studios. ... Final Cut Pro X users can now reveal the media of their split ...
(Date:6/27/2016)... , ... June 27, 2016 ... ... the patient payment industry today announced its strategic partnership with Connance, a ... workflows. , The two companies’ proven, proprietary technology combine to provide health ...
(Date:6/27/2016)... Park, KS (PRWEB) , ... June 27, 2016 , ... ... in retailers of Eyeglasses . , Millions of individuals in the United States ... eyeglasses have become a way to both correct vision and make a fashion statement. ...
(Date:6/26/2016)... ... 2016 , ... On June 10-11, 2016, A Forever Recovery, a holistic treatment ... Longest Breakfast Table in Battle Creek, MI, where the rehabilitation facility is located. This ... of the world’s leading providers of cereal and other breakfast foods. Its residents often ...
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements ... was developed to enhance the health of felines. The formula is all-natural and is ... herbs in the PawPaws Cat Kidney Support Supplement Soft Chews are Astragalus ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... OAKLAND, N.J. , June 24, 2016 /PRNewswire/ ... in the design, development and manufacturing of collagen ... and regeneration announced today that Bill Messer ... Sales and Marketing to further leverage the growing ... surgery medical devices. Bill joins the ...
(Date:6/24/2016)... Va. , June 24, 2016 The ... set of recommendations that would allow biopharmaceutical ... (HCEI) with entities that make formulary and coverage decisions, ... the "value" of new medicines. The recommendations ... does not appear on the drug label, a prohibition ...
(Date:6/24/2016)... , June 24, 2016   Pulmatrix, Inc ., ... developing innovative inhaled drugs, announced today that it was ... Investments reconstituted its comprehensive set of U.S. and ... "This is an important milestone for Pulmatrix," said Chief ... shareholder awareness of our progress in developing drugs for ...
Breaking Medicine Technology: